Spectral Genomic

Spectral Genomics was a biotechnology company specializing in the development and commercialization of array comparative genomic hybridization (aCGH) technology. The company's platform enabled high-resolution screening of the entire genome for DNA copy number variations, which are critical in the study of cancer and constitutional genetic disorders. Their flagship products included the SpectralChip and Constitutional Chip, which provided researchers and clinicians with tools for molecular cytogenetics. Spectral Genomics was a pioneer in transitioning cytogenetics from traditional microscopy-based methods to high-throughput digital genomic analysis. The company was acquired by PerkinElmer in 2006 to bolster its molecular diagnostics and prenatal screening portfolio.